Viatris is trading at $17.36 (+4.1%), extending its multi-day uptrend despite a weaker broader market.

  • The move is largely driven by a rally in healthcare shares following strong earnings results from UnitedHealth.
  • Bullish sentiment continues to build around the company's pipeline, cost-savings program, and high-dividend value profile.
  • The stock's performance comes despite a lack of new company-specific headlines on July 16, 2026, highlighting its strength as a value play.